Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Review article: Biomedical intelligence

Vol. 141 No. 3536 (2011)

Prevention ‒ a cost-effective way to fight the non-communicable disease epidemic

  • N Probst-Hensch
  • M Tanner
  • C Burri
DOI
https://doi.org/10.4414/smw.2011.13266
Cite this as:
Swiss Med Wkly. 2011;141:w13266
Published
29.08.2011

Summary

The United Nations General Assembly has convened a Summit on non-communicable diseases (NCDs), an historic moment in the global combat of these disorders. Lifestyles in increasingly urban and globalised environments have led to a steep surge in NCD incidence in low and middle income countries, where two thirds of all NCD deaths occur (most importantly from cancer, cardiovascular and respiratory disease as well as diabetes). Treatment of NCDs is usually long term and expensive, thus threatening patients’ and nations’ budgets and putting them at high risk for poverty.

The NCD Summit offers an opportunity for strengthening and shaping primary prevention, the most cost-effective instrument to fight major risk factors such as tobacco smoking, alcohol abuse, physical inactivity and unhealthy diet. From a Swiss perspective, we also emphasised the efforts for new laws on prevention and diagnosis registration, in accordance with the recommendations of the NCD summit in order to strengthen primary prevention and disease monitoring. In addition, the need for structural prevention across all policy sectors with leadership in environmental policy making to prevent NCDs as well as the need to adapt and strengthen primary health care are equally relevant for Switzerland. To compliment efforts in primary prevention, the field of NCDs requires special R&D platforms for affordable NCD drugs and diagnostics for neglected population segments in both Switzerland and low and middle income countries. Switzerland has a track record in research and development against diseases of poverty on a global scale that now needs to be applied to NCDs.

References

  1. Beaglehole R, Bonita R, Horton R, Adams C, Alleyne G et al. Priority actions for the non-communicable disease crisis. Lancet. 2011;377:1438–47.
  2. Beaglehole R, Bonita R, Alleyne G, et al. UN High-level meeting on non-communicable diseases: addressing four questions. Lancet. 2011;378:449–55.
  3. UN Secretary-General report: Prevention and control of non-communicable diseases. 19 May 2011.
  4. World Health Organization. Global Malaria Control and Elimination: Report of a Technical Review. WHO 2008, Geneva. Available from: http://www.who.int/malaria/docs/elimination/MalariaControlEliminationMeeting.pdf.
  5. Kathri GR, Frieden TR. Controlling tuberculosis in India. N Engl J Med. 2002;347:1420–5.
  6. Walker C, Unwin N. Estimates of the impact of diabetes on the incidence of pulmonary tuberculosis in different ethnic groups in England. Thorax. 2010;65:578–81.
  7. Jeon CY, Murray MB. Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Med. 2008;5:e152.
  8. Dooley KE, Chaisson RE. Tuberculosis and diabetes mellitus: convergence of two epidemics. Lancet Infect Dis. 2009;9(12):737–46.
  9. World Health Organization. Global status report on non-communicable diseases. 2010. Available from: http://www.who.int/chp/ncd_global_status_report/en/
  10. World Economic Forum. Global risks 2011. Available from: http://www.riskreport.weforum.org/
  11. Smith R. Why we should emphasise prevention over treatment of non-communicable disease. BMJ. 2011;343:d4888:10.1136/bmj.d4888.
  12. Mahal A, Karan A, Engelau M. The economic implications of non communicable disease for India. Washington: World Bank 2010.
  13. OECD/WHO. Reviews of Health Systems. Switzerland. 2006, ISBN 9264025820
  14. Cape well S, O’Flaherty M. Rapid mortality falls after risk factor changes in populations. Lancet 2011. Published online March 16. DOI:10.1016/S0140–6736(10)62302–1.
  15. Genera R, Stickler D, Sachiko S, et al. Raising the priority of preventing chronic diseases: a political process. Lancet. 2010;376:1689–98.
  16. Corbett SJ. Channelling Edwin Chadwick: beyond utopian thinking in urban planning policy and health. NSW Public Health Bulletin. 2007;18(91–10):195–7.
  17. Northridge ME, Freeman L. Urban planning and health equity. Journal of Urban Health: Bulletin of the New York Academy of Medicine. 2011;88:582–97.
  18. Brook RD, Rajagopalan S, Pope CA 3rd, Brook JR, Bhatnagar A, Diez-Roux AV et al. American Heart Association Council on Epidemiology and Prevention, Council on the Kidney in Cardiovascular Disease, and Council on Nutrition, Physical Activity and Metabolism. Particulate matter air pollution and cardiovascular disease: An update to the scientific statement from the American Heart Association. Circulation. 2010;1;121(21):2331–78.
  19. Künzli N, Perez L, Rapp R. Air Quality and Health. Lausanne, Switzerland: ERS2010 September 2010.
  20. Perez L, Rapp R, Kunzli N. The Year of the Lung: outdoor air pollution and lung health. Swiss Med Wkly. 2010;140:w13129.
  21. Krämer U, Herder C, Sugiri D, Strassburger K, Schikowski T, Ranft U, Rathmann W. Traffic-related air pollution and incident type 2 diabetes: results from the SALIA cohort study.Environ Health Perspect. 2010;118(9):1273–9.
  22. Sunyer J. The neurological effects of air pollution in children. Eur Respir J. 2008;32(3):535–7.
  23. Probst-Hensch NM. Chronic age-related diseases share risk factors: do they share pathophysiological mechanisms and why does that matter? Swiss Med Wkly. 2010 Sep 1;140:w13072. doi: 10.4414/smw.2010.13072.
  24. Balakrishnan K, Uma R. Public Health and Air Pollution in Asia (PAPA): Coordinated Studies of Short-Term Exposure to Air Pollution and Daily Mortality in Two Indian Cities. 2011, HEI Publication, Report 157. Available from: http://pubs.healtheffects.org/view.php?id=357.
  25. Kaiser J. ECONOMICS: How Much Are Human Lives and Health Worth? Science. 2003;299(5614):1836–7.
  26. Kjellstrom T, Butler AJ, Lucas RM, Bonita R. Public health impact of global heating due to climate change: potential effects on chronic non-communicable diseases. Int J Public Health. 2010;55:97–103.
  27. Alwan A, MacLean DR, Riley LM, Tursan d’Espaignet E, Mathers CD, Stevens GA et al. Chronic Diseases: Chronic Diseases and Development. Monitoring and surveillance of chronic non-communicable diseases: progress and capacity in high-burden countries. Lancet. 2010;376:1861–8.
  28. Parkin DM. The evolution of the population-based cancer registry. Nat Rev Cancer. 2006;6:603–12.
  29. Oncosuisse, National Cancer Program 2011–2015; http://www.oncosuisse.ch/index_EN.html
  30. Ahmed SM, Hadi A, Razzaque A, Ahsraf A, Juvekar S, Ng N et al. Clustering of chronic non-communicable disease risk factors among selected Asian populations: levels and determinants. Global Health Action. 2009;NCD Supplement: 68–75.
  31. World Bank; World development Report 1993, Investing in Health, World Bank 1993
  32. De Savigny D, Kasale H, Mbuya C, Reid G (eds). Fixing Health Systems (2nd edt.). 2008 International Development Research Center, Ottawa.
  33. De Savigny D, Adam T. Systems thinking for health systems strengthening. Alliance for Health Policy and Systems Research, 2009 WHO Geneva.
  34. Zwahlen M, Low N, Borisch B, Egger M, Künzli N, Obrist R et al. Population based screening ‒ the difficulty of how to do more good than harm and how to achieve it. Swiss Med Wkly. 2010 Sep 13;140: w13061.
  35. Barker DJP. The development origins of chronic adult disease. Acta Paediatr. 2004;446:26–33.
  36. Reyes L, Manalich R. Long-term consequences of low birth weight. Kidney Int. 2005;68:107–11.
  37. Lee PT, Henderson M, Patel VA. A UN summit on global mental health. Lancet. 2010;376:516.
  38. Lotvall J, Akdis CA, Bacharier LB, Bjermer L, Casale TB, Custovic A et al. Asthma endotypes: a new approach to classification of disease entities within the asthma syndrome. J Allergy Clin Immunol. 2011;127(2):355–60.
  39. Boutayeb A. The double burden of communicable and non-communicable diseases in developing countries. Transactions of the Royal Society of Tropical Medicine and Hygiene. 2006;100:191–9.
  40. Clifford GM, Franceschi S. Cancer risk in HIV-infected persons: influence of CD4(+)count. Future Oncol 2009;5:669–78.
  41. Sturm R, Cohen DA. Zoning for health? The year-old ban on new fast-food restaurants in South LA: The ordinance isn’t a promising approach to tackle obesity. Health Aff- 2009;28(6):1088–97.
  42. Spoerri A, Zwahlen M, Egger M, Gutzwiller F, Minder C, Bopp M. Educational inequalities in life expectancy in German speaking part of Switzerland 1990–1997: Swiss National Cohort. Swiss Med Wkly. 2006;136(9–10):145–8.